144 related articles for article (PubMed ID: 22948082)
1. Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium.
Kan-O K; Matsumoto K; Inoue H; Fukuyama S; Asai Y; Watanabe W; Kurokawa M; Araya J; Kuwano K; Nakanishi Y
Int Arch Allergy Immunol; 2013; 160(1):27-36. PubMed ID: 22948082
[TBL] [Abstract][Full Text] [Related]
2. PI3K-delta mediates double-stranded RNA-induced upregulation of B7-H1 in BEAS-2B airway epithelial cells.
Kan-o K; Matsumoto K; Asai-Tajiri Y; Fukuyama S; Hamano S; Seki N; Nakanishi Y; Inoue H
Biochem Biophys Res Commun; 2013 May; 435(2):195-201. PubMed ID: 23660190
[TBL] [Abstract][Full Text] [Related]
3. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
4. Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonists.
Rider CF; Miller-Larsson A; Proud D; Giembycz MA; Newton R
Eur J Pharmacol; 2013 May; 708(1-3):60-7. PubMed ID: 23523474
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-22 attenuates double-stranded RNA-induced upregulation of PD-L1 in airway epithelial cells via a STAT3-dependent mechanism.
Seki N; Kan-O K; Matsumoto K; Fukuyama S; Hamano S; Tonai K; Ota K; Inoue H; Nakanishi Y
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):242-248. PubMed ID: 29032197
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition.
Rossios C; To Y; Osoata G; Ito M; Barnes PJ; Ito K
Br J Pharmacol; 2012 Oct; 167(4):775-86. PubMed ID: 22251095
[TBL] [Abstract][Full Text] [Related]
7. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
Larsson K; Janson C; Lisspers K; Jørgensen L; Stratelis G; Telg G; Ställberg B; Johansson G
J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
[TBL] [Abstract][Full Text] [Related]
8. Long-acting β
Altonsy MO; Mostafa MM; Gerber AN; Newton R
Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L358-L370. PubMed ID: 28039105
[TBL] [Abstract][Full Text] [Related]
9. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements.
Edwards MR; Haas J; Panettieri RA; Johnson M; Johnston SL
J Biol Chem; 2007 May; 282(21):15366-75. PubMed ID: 17395587
[TBL] [Abstract][Full Text] [Related]
11. Effects of corticosteroid plus long-acting beta
Hamano S; Matsumoto K; Tonai K; Fukuyama S; Kan-O K; Seki N; Inoue H; Nakanishi Y
J Inflamm (Lond); 2017; 14():2. PubMed ID: 28115915
[TBL] [Abstract][Full Text] [Related]
12. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma.
Pace E; Gagliardo R; Melis M; La Grutta S; Ferraro M; Siena L; Bonsignore G; Gjomarkaj M; Bousquet J; Vignola AM
J Allergy Clin Immunol; 2004 Nov; 114(5):1216-23. PubMed ID: 15536434
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
[TBL] [Abstract][Full Text] [Related]
16. The effects of asthma medications on reactive oxygen species production in human monocytes.
Tsai MK; Lin YC; Huang MY; Lee MS; Kuo CH; Kuo PL; Lin CH; Hung CH
J Asthma; 2018 Apr; 55(4):345-353. PubMed ID: 28696794
[TBL] [Abstract][Full Text] [Related]
17. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
18. Synergistic suppression of Poly(I:C)-induced CCL3 by a corticosteroid and a long acting β2 agonist in nasal epithelial cells.
Tanaka S; Tamari M; Nakayama T; Ishii H; Hatsushika K; Hayashi A; Watanabe H; Kanai M; Osano M; Yonaga T; Tomita K; Fujieda S; Sakuma Y; Shiono O; Ishitoya J; Masuyama K; Hirota T
Allergol Int; 2015 Apr; 64(2):196-9. PubMed ID: 25838100
[No Abstract] [Full Text] [Related]
19. Long-acting β2 agonists and corticosteroids restore the reduction of histone deacetylase activity and inhibit H2O2-induced mediator release from alveolar macrophages.
Perng DW; Su KC; Chou KT; Wu YC; Chen CS; Hsiao YH; Tseng CM; Chen YH; Hsueh TY; Lee YC
Pulm Pharmacol Ther; 2012 Aug; 25(4):312-8. PubMed ID: 22546485
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
